Evidence map›Paper›PMID 28285583›Full record

ArticleParasites & vectors2017

Molecular detection of vector-borne pathogens in blood and splenic samples from dogs with splenic disease.

Rebeca Movilla, Laura Altet, Lorena Serrano, María-Dolores Tabar, Xavier Roura

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Fatal babesiosis in a free-ranging iberian wolf co-infected withInternational journal for parasitology. Parasites and wildlife · 2025
    Article
  4. Single and co-infections by Anaplasma platys, Babesia vogeli, Ehrlichia canis, and Hepatozoon canis in dogs from Rio Grande do Norte, Brazil: frequency and molecular characterization.Revista brasileira de parasitologia veterinaria = Brazilian journal of veterinary parasitology : Orgao Oficial do Colegio Brasileiro de Parasitologia Veterinaria · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rebeca MovillaHospital Clínic Veterinari, Universitat Autònoma de Barcelona, Carrer de L'Hospital s/n, 08193 Bellaterra, Cerdanyola del Vallès, Barcelona, Spain.
Laura AltetVetgenomics, Edifici Eureka, Parc de Recerca de la Universitat Autònoma de Barcelona, 08193 Bellaterra, Cerdanyola del Vallès, Barcelona, Spain.
Lorena SerranoVetgenomics, Edifici Eureka, Parc de Recerca de la Universitat Autònoma de Barcelona, 08193 Bellaterra, Cerdanyola del Vallès, Barcelona, Spain.
María-Dolores TabarHospital Veterinario San Vicente, Calle del Veterinario Manuel Isidro Rodríguez García N°17, 03690 San Vicente del Raspeig, Alicante, Spain.
Xavier RouraHospital Clínic Veterinari, Universitat Autònoma de Barcelona, Carrer de L'Hospital s/n, 08193 Bellaterra, Cerdanyola del Vallès, Barcelona, Spain. xavier.roura@uab.cat.
Universitat Autònoma de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe spleen is a highly perfused organ involved in the immunological control and elimination of vector-borne pathogens (VBP), which could have a fundamental role in the pathogenesis of splenic disease. This study aimed to evaluate certain VBP in samples from dogs with splenic lesions.

methodsSeventy-seven EDTA-blood and 64 splenic tissue samples were collected from 78 dogs with splenic disease in a Mediterranean area. Babesia spp., Bartonella spp., Ehrlichia/Anaplasma spp., Hepatozoon canis, Leishmania infantum, hemotropic Mycoplasma spp. and Rickettsia spp. were targeted using PCR assays. Sixty EDTA-blood samples from dogs without evidence of splenic lesions were included as a control group.

resultsMore than half (51.56%) of the biopsies (33/64) were consistent with benign lesions and 48.43% (31/64) with malignancy, mostly hemangiosarcoma (25/31). PCR yielded positive results in 13 dogs with spleen alterations (16.67%), for Babesia canis (n = 3), Babesia gibsoni (n = 2), hemotropic Mycoplasma spp. (n = 2), Rickettsia massiliae (n = 1) and "Babesia vulpes" (n = 1), in blood; and for B. canis, B. gibsoni, Ehrlichia canis and L. infantum (n = 1 each), in spleen. Two control dogs (3.3%) were positive for B. gibsoni and H. canis (n = 1 each). Benign lesions were detected in the 61.54% of infected dogs (8/13); the remaining 38.46% were diagnosed with malignancies (5/13). Infection was significantly associated to the presence of splenic disease (P = 0.013). There was no difference in the prevalence of infection between dogs with benign and malignant splenic lesions (P = 0.69); however B. canis was more prevalent in dogs with hemangiosarcoma (P = 0.006).

conclusionsVBP infection could be involved in the pathogenesis of splenic disease. The immunological role of the spleen could predispose to alterations of this organ in infected dogs. Interestingly, all dogs with B. canis infection were diagnosed with hemangiosarcoma in the present survey. As previously reported, results support that VBP diagnosis could be improved by analysis of samples from different tissues. The sample size included here warrants further investigation.

Indexed as

AnaplasmaAnaplasmosisAnimalsBabesiaBabesiosisBartonellaBartonella InfectionsDisease VectorsDog DiseasesDogsEhrlichia canisEhrlichiosisLeishmania infantumLeishmaniasis, VisceralMycoplasmaMycoplasma InfectionsBabesia canisCanineHemangiosarcomaPolymerase chain reactionSpleenVector-borne disease

Identifiers

PMID28285583
PMCPMC5346854
OpenAlexW2591934438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.